Myriad Genetics to Host Investor Event on October 9, 2024
SALT LAKE CITY, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and...
SALT LAKE CITY, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and...
ARQ-255 is a topical Janus kinase 1 (JAK1) inhibitor suspension formulated as a potential topical treatment for alopecia areataProprietary Deep...
Top-line data from VEGA-3 Phase 3 trial expected in first half of 2025 Top-line data from LYNX-2 Phase 3 trial...
ORANGE, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Alignment Health, a consumer brand name of Alignment Healthcare, Inc. (NASDAQ: ALHC),...
WALTHAM, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to...
BOSTON, Mass. and SHANGHAI, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Eccogene, a clinical-stage biopharmaceutical company developing next-generation oral small molecule...
TTP Group is a leading engineering firm specializing in biotech and pharmaceutical industryThe company serves blue-chip clients in Europe TTP Group...
More options for smoother bioprocessing workflows and greater data reliability STAUFEN, Germany, Sept. 5, 2024 /PRNewswire/ -- IKA, a global company in...
NANJING, China, Sept. 5, 2024 /PRNewswire/ -- On September 2, 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets...
PALO ALTO, CA / ACCESSWIRE / September 5, 2024 / Bioz, Inc., a leader in AI-driven research efficiency solutions, is...